use
metagenom
microarray
detect
genom
rna
human
pegiviru
serum
cerebrospin
fluid
patient
suffer
sever
enceph
pathogen
detect
hpgv
cerebrospin
fluid
enceph
never
report
preval
cerebrospin
fluid
need
investig
metagenom
methodolog
excel
complement
case
diagnosi
difficult
establish
convent
laboratori
test
usag
ever
increas
metagenom
approach
reveal
presenc
pathogen
commens
patient
sampl
focu
identifi
underli
etholog
agent
specif
diseas
condit
report
case
sever
enceph
microb
detect
cn
human
pegiviru
hpgv
hitherto
known
caus
asymptomat
infect
human
one
previou
report
describ
detect
hpgv
brain
tissu
csf
case
uncertain
hpgv
pathogen
noteworthi
detect
viru
high
viral
load
cn
case
hpgv
infect
associ
benefici
outcom
patient
dualli
infect
hpgv
hiv
ebola
old
danish
femal
admit
hospit
abdomin
pain
vomit
dizzi
lower
extrem
pain
work
bartend
cruis
ship
sexual
activ
travel
histori
outsid
scandinavia
exposur
blood
transfus
intraven
drug
close
contact
anim
albeit
recent
receiv
tattoo
past
medic
histori
includ
radiofrequ
cathet
ablat
wolfparkinsonwhit
syndrom
await
elect
cholecystectomi
due
prior
gallston
attack
upon
admiss
alert
circulatori
stabl
fever
c
glasgow
coma
score
bmi
routin
blood
test
show
haemoglobin
mmoll
white
blood
cell
count
l
lymphocytopenia
normal
platelet
count
creactiv
protein
crp
mgl
alanin
aminotransferas
ul
lactat
dehydrogenas
ul
alkalin
phosphatas
ul
bilirubin
moll
acut
laparoscop
cholecystectomi
perform
patholog
gall
bladder
found
immedi
follow
surgeri
develop
increas
abdomin
pain
fever
underw
explor
laparoscopi
normal
find
postop
patient
complain
headach
diplopia
disappear
within
h
discharg
hospit
howev
readmit
follow
day
fever
headach
sudden
behavior
chang
photosensit
ataxia
present
somnol
neck
stiff
physic
examin
glasgow
coma
score
vital
sign
within
normal
limit
fever
c
peripher
blood
show
crp
mgl
white
blood
count
pleocytosi
cellsmm
lymphocyt
increas
protein
concentr
gl
indic
viral
infect
mri
brain
reveal
leptomening
enhanc
right
hemispher
togeth
parenchym
chang
consist
meningoenceph
treat
aciclovir
suspect
viral
enceph
meropenem
possibl
bacteri
infect
follow
day
patient
worsen
mental
statu
deterior
progress
coma
transfer
intens
care
unit
mechan
ventil
repeat
lumbar
punctur
day
disclos
increas
mononuclear
cell
leukocytesmm
lymphocyt
protein
concentr
gl
receiv
dexamethason
methylprednisolon
later
prednisolon
serum
csf
test
relev
pathogen
return
neg
tabl
lack
specif
diagnosi
serum
csf
sent
staten
serum
institut
copenhagen
specimen
run
lawrenc
livermor
panmicrobi
array
array
contain
probe
sequenc
bacteria
virus
present
ncbi
databas
posit
signal
human
pegiviru
hpgv
acc
nr
two
separ
diagnost
laboratori
subsequ
confirm
hpgv
rna
serum
csf
ct
valu
hpgv
acut
phase
serum
spinal
fluid
respect
rnaseq
librari
prepar
serum
sequenc
illumina
platform
obtain
type
inform
read
map
entir
refer
genom
acc
nr
nc
mean
sequenc
depth
pariwis
ident
nt
aa
respect
assembl
sequenc
acc
nr
cluster
within
genotyp
eight
day
sever
neurolog
symptom
patient
gradual
recov
discharg
hospit
four
week
later
rehabilit
five
week
discharg
still
virem
hpgv
serum
viral
load
decreas
time
ct
hpgv
flaviviru
character
envelop
virion
singlestrand
positivesens
rna
genom
close
relat
hepat
c
viru
upon
discoveri
hpgv
initi
thought
caus
acut
hepat
later
disproven
hpgv
infect
link
clinic
diseas
human
contrari
infect
associ
benefici
outcom
hiv
patient
also
recent
ebola
infect
individu
radkowski
et
al
screen
sampl
patient
suffer
asept
mening
enceph
rtpcr
could
detect
hpgv
sampl
recent
posit
neg
rnastrand
hpgv
detect
post
mortem
brain
tissu
multipl
sclerosi
ms
patient
impli
viru
replic
brain
tissu
author
also
detect
hpgv
csf
patient
screen
csf
addit
ms
patient
neg
develop
countri
healthi
blood
donor
virem
hpgv
denmark
wherea
develop
countri
peopl
bloodborn
sexual
transmit
diseas
preval
reach
clearanc
hpgv
coincid
appear
hpgv
antibodi
healthi
individu
normal
clear
infect
within
two
year
popul
seroposit
glycoprotein
reflect
previou
infect
hpgv
routin
test
ill
cn
surpris
detect
csf
patient
posit
find
analyz
addit
csf
sampl
enceph
patient
patient
relaps
ms
hpgv
qpcr
enceph
sampl
test
serum
collect
concurr
csf
sampl
csf
sampl
neg
hpgv
one
enceph
patient
posit
serum
ct
interestingli
patient
also
csf
pleocytosi
case
patient
hpgv
lymphotrop
presenc
hpgv
csf
could
attribut
passiv
transport
viru
cell
recruit
csf
uncertain
hpgv
infect
presenc
csf
way
influenc
clinic
present
possibl
exclud
week
discharg
still
virem
hpgv
viral
load
serum
decreas
ct
seem
rare
occas
hpgv
enter
cn
high
viral
titer
unknown
long
persist
clearanc
viru
csf
well
understood
process
herpesviru
cmv
ebv
vzv
hsv
flaviviru
tbev
persist
individu
enceph
may
caus
recurr
enceph
also
exclud
possibl
enceph
result
reactiv
event
due
surgic
procedur
patient
neg
hsv
symptom
coincid
time
surgeri
sever
virus
bacteria
antibodi
known
abl
induc
enceph
mani
clinic
case
etiolog
remain
unknown
metagenom
methodolog
target
multitud
microb
simultan
therebi
reduc
number
test
total
cost
due
unbias
present
nucleic
acid
present
sampl
unpreced
potenti
diagnost
tool
differenti
diagnosi
ng
use
resolv
presenc
leptospira
santarosai
astroviru
csf
case
enceph
comprehens
microbiolog
test
inconclus
precis
interpret
need
develop
pathogen
nonpathogen
microb
yield
signal
perhap
disclos
known
viru
unexpect
pathogenet
potenti
whether
presenc
hpgv
csf
affect
diseas
progress
remain
establish
find
need
report
add
knowledg
microbi
flora
aid
pinpoint
microb
warrant
attent
studi
